Immunotec Announces Agreement

Immunotec Inc. (TSX VENTURE:IMM), a Canadian based company and a leader in the
wellness industry (the "Company") and Mr. Robert Henry, its former Chairman and
Chief Executive Officer, are pleased to announce that they have amicably
concluded a final settlement to their mutual satisfaction with respect to the
claims regarding Mr. Henry's past involvement with the Company, for a total
amount payable to Mr. Henry of USD$522,000.


The Company thanks Mr. Henry for his contribution to the Company. Mr. Henry also
expresses his appreciation to the Company's founders, the management team and
the Company's employees, distributors and customers.


About Immunotec Inc. 

Immunotec Inc. is dedicated to making a positive difference in people's health
and lifestyle every day by offering research-driven nutritional products through
its network of Independent Consultants worldwide. Immunotec's products are led
by the flagship brand, Immunocal. Immunocal is a unique, specially-formulated
natural protein product that has been clinically demonstrated and patented to
optimize your immune system. Immunotec's strength comes from its culture that
emphasizes teamwork and entrepreneurial leadership by employees, consultants and
research collaborators.


Headquartered with manufacturing facilities near Montreal, Canada, Immunotec
Consultants generate nearly $50 Million in annual revenue. Please visit us at
www.immunotec.com for additional information.


The Company files its consolidated financial statements, its management and
discussion analysis report, its press releases and such other required documents
on the SEDAR database at www.sedar.com and on the Company's website at
www.immunotec.com. The common shares of the Company are listed on the TSX
Venture Exchange under the ticker symbol IMM. 


Neither TSX Venture Exchange nor its Regulation Services Provider (as that term
is defined in policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release. 


CAUTION REGARDING FORWARD-LOOKING STATEMENTS: Certain statements contained in
this news release are forward-looking and are subject to numerous risks and
uncertainties, known and unknown. For information identifying known risks and
uncertainties and other important factors that could cause actual results to
differ materially from those anticipated in the forward-looking statements,
please refer to the heading Risks and Uncertainties in Immunotec's most recent
Management's Discussion and Analysis, which can be found at www.sedar.com.
Consequently, actual results may differ materially from the anticipated results
expressed in these forward-looking statements.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Immunotec Inc.
Patrick Montpetit CPA; CA CF
Vice President and Chief Financial Officer
[phone]
www.immunotec.com